Skip to content

Effect of garlic tables on with diabetes type 2

Effect of garlic tables on glucose,lipid profile . visfatin and leptin inpatients with diabetes type 2

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014070813160N4
Enrollment
50
Registered
2014-11-22
Start date
2013-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus type 2. Diabetes mellitus

Interventions

Intervention 1: Intervention group:Taking 3 tablets of 400 mg of garlic, for 12 weeks. Intervention 2: Control group: Taking 3 placebo tablets at doses of 400 mg for 12 weeks.
Treatment - Drugs
Intervention group:Taking 3 tablets of 400 mg of garlic, for 12 weeks
Control group: Taking 3 placebo tablets at doses of 400 mg for 12 weeks

Sponsors

Vice Chancellor Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria for Control and Intervention group : age between 20 to 60 years ; have diabetes and their diabetes have been diagnosed for 5 years. Exclusion Criteria for Control and Intervention group : Disorders and diseases of the kidney, liver, heart - cardiovascular, blood pressure, thyroid and cancer ; Taking vitamin supplements or antioxidant in recent months ; Pregnancy and lactation ; insulin injections ; Smoking during the last 5 to 6 years ; Participation in another research project ; less than 80 percent of people who took garlic tablets ; People who have a change in the type and dose of your medication

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
HbA1c. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Enzymatic colorimetric( GOD-PAP)Photometric method for single point measurements.

Secondary

MeasureTime frame
HDL. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Enzymatic colorimetric( GOD-PAP)Photometric method for single point measurements.;LDL. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Enzymatic colorimetric( GOD-PAP)Photometric method for single point measurements.;CHO. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Enzymatic colorimetric( GOD-PAP)Photometric method for single point measurements.;TG. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Enzymatic colorimetric( GOD-PAP)Photometric method for single point measurements.;Waist. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Meter.;Blood pressure. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Sphygmomanometer.;Leptin hormon. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: ELISA method.;Visfatin hormon. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: ELISA method.;Fasting blood glucose. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Enzymatic colorimetric( GOD-PAP)Photometric method for single point measurements.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMozafari doctor

University of Medical Sciences, Yazd

mozaffari.kh@gmail.com+98 35 1624 0691

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026